Market Clearances

BioElectronics Worldwide  Class IIa OTC Market Clearances

BioElectronics Regulatory Logos

US FDA – The treatment of edema following blepharoplasty.

US FDA (Pending) –

  • RecoveryRx® Indication-of-use: Postoperative pain and edema.
  • ActiPatch® OTC indication-of-use: Relief of musculoskeletal pain.
  • Allay® OTCindication-of-use: Relief of menstrual pain and discomfort.

European Union (CE)
For the reduction of pain and Inflammation (OTC).

Health Canada Relief of pain associated with musculoskeletal complaints, relief of menstrual pain, and postoperative OTC.

Australia (TGA) For the reduction of pain and inflammation.

Korea Reduction of muscle pain.

Many others around the world.